Moreover, it has been shown that PTEN knockdown or pharmacological inhibition is beneficial for MN survival and neuromuscular innervation in non-FUS ALS and spinal muscular atrophy models [46–48, 56]. This evidence concerns the gene PTEN and amyotrophic lateral sclerosis.